C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor

Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
03/2011
03/17/2011	US20110065691 Therapeutic piperazines
03/17/2011	US20110065690 Compositions and methods for treatment of leukemia
03/17/2011	US20110065675 Azo dye related small molecule modulators of protein-protein interactions
03/17/2011	US20110065650 Methods of Inhibiting Tumor Cell Proliferation
03/17/2011	US20110065645 Compositions and Methods for Modulating Neuron Degeneration and Neuron Guidance
03/17/2011	US20110065644 Compositions comprising human pcsk9 and apolipoprotein b sirna and methods of use
03/17/2011	US20110065641 Polypeptide and dna thereof useful as a neovascular marker
03/17/2011	US20110065640 Anti-invasive and anti-angiogenic compositions
03/17/2011	US20110065636 Screening and Therapy for Lymphatic Disorders Involving the FLT4 Receptor Tyrosine Kinase (VEGFR-3)
03/17/2011	US20110065192 Embryonic stem cell line and method for preparing the same
03/17/2011	US20110065191 Isolated nucleic acids encoding farnesyltransferase polypeptides
03/17/2011	US20110065190 Blood platelet induction method
03/17/2011	US20110065189 Lacritin-Syndecan Interactions
03/17/2011	US20110065188 Paracrine signals from mesenchymal feeder cells and regulating expansion and differentiation of hepatic progenitors using same
03/17/2011	US20110065187 Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
03/17/2011	US20110065186 Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
03/17/2011	US20110065185 Mutated anti-cd22 antibodies with increased affinity to cd22-expressing leukemia cells
03/17/2011	US20110065184 Human host cell for producing recombinant proteins with high quality and quantity
03/17/2011	US20110065183 Methods and Apparatus for Isolating Platelets From Blood
03/17/2011	US20110065182 Modified DNA Cleavage and Methods for Use
03/17/2011	US20110065181 Methods and Apparatus for Segregation of Particles
03/17/2011	US20110065180 Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
03/17/2011	US20110065179 Transgene delivering retrovirus targeting collagen exposed at site of tissue injury
03/17/2011	US20110065178 Dendritic cell potentiation
03/17/2011	US20110065177 Novel Collectin
03/17/2011	US20110065176 Human monoclonal antibody neutralizing vascular endothelial growth factor receptor and use thereof
03/17/2011	US20110065175 Artificially synthesized peptide
03/17/2011	US20110065174 Hepatitis c virus codon optimized non-structural ns3/4a fusion gene
03/17/2011	US20110065167 Degradation of Hydrophobic Ester Pesticides and Toxins
03/17/2011	US20110065158 Regulation of plant metabolism
03/17/2011	US20110065147 Methods and reagents for modulating cholesterol levels
03/17/2011	US20110065146 Expression of HIV polypeptides and production of virus-like particles
03/17/2011	US20110065142 Sebocytes, sebocyte-cell line and uses thereof
03/17/2011	US20110065132 Identification of Actinobacillus actinomycetemcomitans Antigens for use in the Diagnosis, Treatment and Monitoring of Periodontal Diseases
03/17/2011	US20110065131 Assays for mutagenesis detection
03/17/2011	US20110065124 Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses
03/17/2011	US20110065123 Methods for diagnosis of Clostridium difficile and methods and vectors for recombinant toxin expression
03/17/2011	US20110065122 Method for accessing microbial diversity
03/17/2011	US20110065118 Drug Screening Using Islet Cells and Islet Cell Progenitors from Human Embryonic Stem Cells
03/17/2011	US20110065114 Steroidogenesis modified cells and methods for screening for endocrine disrupting chemicals
03/17/2011	US20110065109 Rna interference mediating small rna molecules
03/17/2011	US20110065103 Use of rna for reprogramming somatic cells
03/17/2011	US20110065100 Transcription biomarkers of biological responses and methods
03/17/2011	US20110065089 Novel strain of sars-associated coronavirus and applications thereof
03/17/2011	US20110065083 Compositions and Methods for Enhancing the Viability of Animal Cells, Tissues, and Organ Explants
03/17/2011	US20110064809 Scaffolds
03/17/2011	US20110064792 Method for Opening Tight Junctions
03/17/2011	US20110064786 Novel use of basic fibroblast growth factor in the de-differentiation of animal connective tissue cells
03/17/2011	US20110064772 Viral adjuvants
03/17/2011	US20110064770 Immunization of an Individual Against Carcinomas and the Preliminary Stages Thereof
03/17/2011	US20110064763 Lentiviral vectors pseudotyped with a sindbis virus envelope glycoprotein
03/17/2011	US20110064761 Novel sequences of brachyspira, immunogenic compositions, methods for preparation and use thereof
03/17/2011	US20110064757 Nucleic acid molecules and polypeptides for immune modulation
03/17/2011	US20110064751 Targeted immunoconjugates
03/17/2011	US20110064733 Ca6 antigen-specific cytotoxic conjugate and methods of using the same
03/17/2011	US20110064730 Method of modulating angiogenesis
03/17/2011	US20110064728 IL-17 Homologous Polypeptides and Therapeutic Uses Thereof
03/17/2011	US20110064726 ANTI IgE ANTIBODIES
03/17/2011	US20110064725 High affinity, anti-human ige antibodies
03/17/2011	US20110064722 Modulators of alpha-synuclein toxicity
03/17/2011	US20110064705 Hemangio colony forming cells and non-engrafting hemangio cells
03/17/2011	US20110064704 Ship-deficiency to increase megakaryocyte and platelet production
03/17/2011	US20110064701 Pluripotent embryonic-like stem cells, compositions, methods and uses thereof
03/17/2011	US20110064700 Neural stem cells
03/17/2011	US20110064692 Human bone-forming cells in the treatment of conditions and bone diseases associated with immunodeficiency or immunosuppression
03/17/2011	US20110064689 In situ immunization
03/17/2011	US20110064682 Cosmetic composition comprising a stem-cell culture fluid, and a production method therefor
03/17/2011	US20110064667 Azide modified proteins
03/17/2011	US20110064651 Recombinant nucleotide sequence, cell or vector containing the same and method for using cell containing the same to encode anti-polyethylene glycol monoclonal antibodies
03/17/2011	CA2772590A1 Antibodies against glucagon receptor and their use
03/17/2011	CA2772400A1 A novel protein delivery system to generate induced pluripotent stem (ips) cells or tissue-specific cells
03/17/2011	CA2771908A1 Umbilical cord amniotic membrane products
03/17/2011	CA2770555A1 Spontaneously contracting fish cell aggregates, use thereof and method for the production thereof
03/17/2011	CA2714790A1 Wheat plants with immunity to wsmv
03/16/2011	EP2295588A1 Novel artificial antigen presenting cells and uses thefor
03/16/2011	EP2295584A2 Transgenic plant-based methods for plant pests using RNAi
03/16/2011	EP2295576A1 BMP-12, BMP-13 and tendon-inducing compositions thereof
03/16/2011	EP2295575A2 Cytotoxic T-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer
03/16/2011	EP2295574A1 Human orphan G protein-coupled receptors
03/16/2011	EP2295573A1 Human orphan G protein-coupled receptors
03/16/2011	EP2295572A1 Human orphan G protein-coupled receptors
03/16/2011	EP2295568A2 Use of poly-alpha2,8-sialic acid mimetic peptides to modulate ncam functions
03/16/2011	EP2295565A1 Polynucleotide for releasing recombinant protein to the outside of eukaryotic cell
03/16/2011	EP2295563A1 B-amylase, gene coding therefor and manufacturing method thereof
03/16/2011	EP2295553A1 Phytase variants
03/16/2011	EP2295551A1 Thermostable reverse transcriptases and uses thereof
03/16/2011	EP2295549A1 Nicotiana nucleic acid molecules and uses thereof
03/16/2011	EP2295541A1 Pluripotent stem cell derived from cardiac tissue
03/16/2011	EP2295540A1 Bioengineered tissue constructs and methods for producing and using them
03/16/2011	EP2295539A1 Cell fractions containing cells capable of differentiating into neural cells
03/16/2011	EP2295538A1 Method for production of pluripotent stem cell
03/16/2011	EP2295537A1 Human hepatic stem cell, method for preparation of the same, method for induction of differentiation of the same, and method for utilization of the same
03/16/2011	EP2295533A2 Dry powder cells and cell culture reagents and methods of production thereof
03/16/2011	EP2295532A1 High-throughput cell-based assays fabricated with integrated silicon and cell culture technologies
03/16/2011	EP2295469A2 Monoclonal antibodies against claudin-18 for treatment of cancer
03/16/2011	EP2295468A1 Anti-CD20 antibodies and fusion proteins thereof and methods of use
03/16/2011	EP2295467A1 Human monoclonal antibody against a costimulatory signal transduction molecule AILIM and pharmaceutical use thereof
03/16/2011	EP2295465A2 Human monoclonal antibodies to influenza M2 protein and methods of making and using same
03/16/2011	EP2295456A1 Albumin fusion proteins
03/16/2011	EP2295455A1 Cytokine receptor

1 ... 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 ... 1827